Suppr超能文献

标准 CD44 通过正反馈环调节肝癌中的 YAP1。

Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.

机构信息

Department of Medical Oncology and Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China; Key Laboratory of Cell Engineering of Guizhou, The Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, 573003, PR China.

Department of Medical Oncology and Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, PR China.

出版信息

Biomed Pharmacother. 2018 Jul;103:147-156. doi: 10.1016/j.biopha.2018.03.042. Epub 2018 Apr 24.

Abstract

High expression levels of CD44 and YAP have been identified as poor prognostic factors in hepatocellular carcinoma (HCC). However, the mechanistic relationship between CD44 and YAP during HCC tumorigenesis remains largely unknown. To investigate the mutual regulation between standard CD44 (CD44S) and YAP1 in HCC cell lines and tissue samples, CD44S and YAP1 expression in 40 pairs of tumor samples and matched distal normal tissues from HCC patients was examined by immunohistochemical staining. High expression of either CD44S or YAP1 was associated with a younger age and worse pathology grade. In addition, high levels of CD44S and YAP1 were associated with increased vascular invasion and more severe liver cirrhosis, respectively. CD44S expression was positively correlated with YAP1 expression in these HCC tissues. In vitro experiments suggested that CD44S could positively regulate the expression of YAP1 and its target genes via the PI3K/Akt pathway in HCC cells. Moreover, CD44S is regulated by the YAP1/TEAD axis. These results reveal a novel positive feedback loop involving CD44S and YAP1, in which CD44S functions as both an upstream regulator and a downstream effector of YAP1 in HCC. This feedback loop might constitute a broadly conserved module for regulating cell proliferation and invasion during HCC tumorigenesis. Blocking this positive feedback loop that involves CD44S and YAP1 might represent a new approach for HCC treatment.

摘要

CD44 和 YAP 的高表达水平被鉴定为肝细胞癌 (HCC) 的不良预后因素。然而,CD44 和 YAP 之间在 HCC 肿瘤发生过程中的机制关系在很大程度上仍然未知。为了研究 HCC 细胞系和组织样本中标准 CD44(CD44S)和 YAP1 之间的相互调节作用,通过免疫组织化学染色检查了来自 HCC 患者的 40 对肿瘤样本和配对的远端正常组织中的 CD44S 和 YAP1 表达。CD44S 或 YAP1 的高表达与更年轻的年龄和更差的病理分级相关。此外,CD44S 和 YAP1 的高水平分别与血管侵犯增加和更严重的肝硬化相关。在这些 HCC 组织中,CD44S 的表达与 YAP1 的表达呈正相关。体外实验表明,CD44S 可以通过 HCC 细胞中的 PI3K/Akt 途径正向调节 YAP1 及其靶基因的表达。此外,CD44S 受 YAP1/TEAD 轴的调节。这些结果揭示了一个涉及 CD44S 和 YAP1 的新的正反馈回路,其中 CD44S 作为 HCC 中 YAP1 的上游调节剂和下游效应物发挥作用。这个反馈回路可能构成了一个广泛保守的模块,用于调节 HCC 肿瘤发生过程中的细胞增殖和侵袭。阻断涉及 CD44S 和 YAP1 的这个正反馈回路可能代表 HCC 治疗的一种新方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验